Representativeness of a National Heart Failure Quality-of-Care Registry
- 1 July 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Cardiovascular Quality and Outcomes
- Vol. 2 (4), 377-384
- https://doi.org/10.1161/circoutcomes.108.822692
Abstract
Background— Participation in clinical registries is nonrandom, so participants may differ in important ways from nonparticipants. The extent to which findings from clinical registries can be generalized to broader populations is unclear. Methods and Results— We linked data from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF) registry with 100% inpatient Medicare fee-for-service claims to identify matched and unmatched patients with heart failure. We evaluated differences in baseline characteristics and mortality, all-cause readmission, and cardiovascular readmission rates. We used Cox proportional hazards models to examine relationships between registry enrollment and outcomes, controlling for baseline characteristics. There were 25 245 OPTIMIZE-HF patients in the Medicare claims data and 929 161 Medicare beneficiaries with heart failure who were not enrolled in OPTIMIZE-HF. Although hospital characteristics differed, patient demographic characteristics and comorbid conditions were similar. In-hospital mortality for OPTIMIZE-HF and non–OPTIMIZE-HF patients was not significantly different (4.7% versus 4.5%; P =0.37); however, OPTIMIZE-HF patients had slightly higher 30-day (11.9% versus 11.2%; P P Conclusions— Characteristics and outcomes of Medicare beneficiaries enrolled in OPTIMIZE-HF are similar to the broader Medicare population with heart failure, suggesting that findings from this clinical registry may be generalized.Keywords
This publication has 16 references indexed in Scilit:
- Linking inpatient clinical registry data to Medicare claims data using indirect identifiersAmerican Heart Journal, 2009
- Prospective Evaluation of Beta-Blocker Use at the Time of Hospital Discharge as a Heart Failure Performance Measure: Results From OPTIMIZE-HFJournal of Cardiac Failure, 2007
- Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure: A Report From the OPTIMIZE-HF RegistryJournal of the American College of Cardiology, 2007
- Registries: what level of evidence do they provide?International Urogynecology Journal, 2007
- Influence of a Performance-Improvement Initiative on Quality of Care for Patients Hospitalized With Heart FailureArchives of Internal Medicine, 2007
- Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registryEuropean Heart Journal, 2007
- Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: An analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)American Heart Journal, 2007
- Are registry hospitals different? A comparison of patients admitted to hospitals of a commercial heart failure registry with those from national and community cohortsAmerican Heart Journal, 2006
- Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and designAmerican Heart Journal, 2004
- The Robust Inference for the Cox Proportional Hazards ModelJournal of the American Statistical Association, 1989